Cloning and the Debate on Abortion
By Nigel Cameron and Lori Andrews,
Chicago Tribune
| 08. 08. 2001
Italian fertility specialist Severino Antinori has announced
that he will begin human cloning in early 2002. Two hundred
couples desperately seeking to create children will become human
guinea pigs in a massive experiment. The odds are not in their
favor. In animals, cloning currently only results in a successful
pregnancy 3 to 5 percent of the time. And, even in those rare
instances, many of the resulting offspring suffer. One-third
die shortly before or right after birth. Other cloned animals
seem perfectly healthy at first and then suffer heart and blood
vessel problems, underdeveloped lungs, diabetes, immune system
deficiencies and severe growth abnormalities.
If an infectious disease were killing one-third of human infants,
we would declare it a public health emergency. We certainly
wouldn’t set up a clinic to enable it to happen. Yet despite
these grave risks, only five states have laws banning human
cloning. There is no federal law on the subject yet. Despite
widespread public opposition to human cloning, various researchers
and biotech companies have so far prevented the passage of such
a law.
This summer, however...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By Sarah A. Topol, The New York Times Magazine | 12.14.2025
The women in House 3 rarely had a chance to speak to the women in House 5, but when they did, the things they heard scared them. They didn’t actually know where House 5 was, only that it was huge...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...